Stockholders’ equity (Details Narrative) - USD ($) |
6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Apr. 30, 2026 |
Apr. 20, 2026 |
Jun. 30, 2026 |
Dec. 31, 2025 |
Sep. 29, 2025 |
|
| Subsidiary, Sale of Stock [Line Items] | |||||
| Common stock, par value | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||
| Contractual life | 10 years | ||||
| Outstanding option | 3,200,000 | ||||
| Weighted average grant date fair value | $ 0.66 | ||||
| Intrinsic value | $ 0 | ||||
| Restricted Awards And Stock Options [Member] | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Unrecognized compensation cost | $ 915,846 | ||||
| Estimated weighted - average amortization period | 3 years 3 months 18 days | ||||
| 2025 Equity Incentive Plan [Member] | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Equity incentive plan percentage | 15.00% | ||||
| Outstanding stock maximum | 4.00% | ||||
| Warrant [Member] | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Outstanding warrants | 9,141,055 | ||||
| Exercisable warrants | 9,141,055 | ||||
| Weighted average exercise price | $ 1.66 | ||||
| Weighted average remaining contractual term | 1 year 6 months | ||||
| Consultants [Member] | Restricted Stock Units (RSUs) [Member] | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Shares granted | 150,000 | ||||
| Subscription Agreement [Member] | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Net proceeds from issuance | $ 14,820,975 | ||||
| Subscription Agreement [Member] | Investor [Member] | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Shares issued | 470,000 | ||||
| Gross proceeds | $ 1,880,000 | ||||
| Proceeds from offering | $ 16,975,412 | ||||
| Investors closing transaction description | (i) a cash fee equal to ten percent (10%) of the gross proceeds delivered to the Company on a closing date by parties introduced by the Placement Agent and (ii) five percent (5%) of the gross proceeds delivered to the Company on a closing date by parties introduced by the Company, as well as a non-allocable expense reimbursement equal to two (2%) of the gross proceeds delivered by Placement Agent introduced investors on a closing date to the Company, and one (1%) of the gross proceeds delivered by Company introduced investors on a closing date to the Company. The Placement also received, at the final closing of the private placement, warrants to purchase shares of Common Stock in an amount equal to ten percent (10%) of the Common Stock sold to Placement Agent introduced parties which are exercisable for five (5) years and have an exercise price equal to 120% of the lowest price per share of the shares of Common Stock issued or issuable to investors in the Offering. The Company agreed to pay certain other expenses of the Placement Agent, including the fees and expenses of its counsel, in connection with the Offering. Subject to certain customary exceptions, the Company also indemnified the Placement Agent to the fullest extent permitted by law against certain liabilities that may be incurred in connection with the Offering, including certain civil liabilities under the Securities Act of 1933, and, where such indemnification is not available, to contribute to the payments the Placement Agent and its sub-agents may be required to make in respect of such liabilities. | ||||
| Direct and incremental issuance costs | $ 2,154,437 | ||||
| Subscription Agreement [Member] | Private Placement [Member] | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Number of shares sold | 3,773,853 | ||||
| Common stock, par value | $ 0.0001 | ||||
| Number of shares sold, value | $ 15,095,412 | ||||
| Purchase price per share | $ 4.00 | ||||
| Number of warrants issued | 374,761 | ||||
| Restricted Stock Awards [Member] | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Award vesting rights description | The stock vests over four years with a 1-year cliff from the grant date |